Suzanne Trudel, Guldane Cengiz Seval, Sosana Delimpasi, Vladimir I. Vorobyev, Hang Quach, Ivan Špička, Jakub Radocha, Youngil Koh, Pawel Robak, Felipe de Arriba de la Fuente, Esther González García, Silvia Mangiacavalli, Margaret Polinkovsky, Jie Ma, Ainslee Moore, Kelly Brock, Joanna Grams, Elisabet Manasanch, María-Victoria Mateos, Meletios A. Dimopoulos. "Long-term outcomes with sustained minimal residual disease (MRD) negativity in belantamab mafodotin–treated patients (pts) with relapsed/refractory multiple myeloma (RRMM): An update from DREAMM-8.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7515